Director Akira Takata granted 390 SITIME (SITM) restricted stock units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Takata Akira reported acquisition or exercise transactions in this Form 4 filing.
SITIME Corp director Akira Takata reported receiving a grant of 390 shares of Common Stock in the form of a restricted stock unit award. The award was granted at no cash cost and will vest in full on May 20, 2027. After this award, Takata holds 12,624 shares of SITIME Common Stock directly, including the unvested units.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Takata Akira
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 390 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 12,624 shares (Direct, null)
Footnotes (1)
- Restricted stock unit award vests fully on May 20, 2027. Includes an aggregate of 390 shares of common stock issuable pursuant to the restricted stock unit award reported pursuant to this Form 4 that has not yet vested.
Key Figures
RSU grant size: 390 shares
Grant price per share: $0.0000 per share
Total shares after transaction: 12,624 shares
+1 more
4 metrics
RSU grant size
390 shares
Restricted stock unit award to director Akira Takata
Grant price per share
$0.0000 per share
Equity compensation, not open-market purchase
Total shares after transaction
12,624 shares
Direct holdings following RSU award, including unvested units
RSU vesting date
May 20, 2027
Full vesting date for 390-share restricted stock unit award
Key Terms
restricted stock unit award, Form 4, Common Stock
3 terms
restricted stock unit award financial
"Restricted stock unit award vests fully on May 20, 2027."
A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.
Form 4 regulatory
"issuable pursuant to the restricted stock unit award reported pursuant to this Form 4"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Common Stock financial
"Includes an aggregate of 390 shares of common stock issuable"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What insider transaction did SITIME (SITM) director Akira Takata report?
Director Akira Takata reported an acquisition of 390 shares of SITIME Common Stock through a restricted stock unit award. The grant was recorded on a Form 4 filing as a compensation-related award rather than an open-market purchase.
When do Akira Takata’s new SITIME (SITM) restricted stock units vest?
The restricted stock unit award vests fully on May 20, 2027. Until that date, the 390 shares are issuable upon vesting and remain subject to the award’s vesting conditions as described in the Form 4 footnotes.
Is this SITIME (SITM) Form 4 transaction a buy or a compensation award?
The transaction is a compensation award, not a market buy. It is coded as an “A” transaction for a grant or award acquisition, with a price of $0.0000 per share, reflecting equity granted to the director rather than purchased shares.